Clinical programs advance on multiple fronts, with trial initiation, trial enrollment, data and IP milestones achieved and anticipated Commercial strategy reinforced with product acquisition and upcoming commercial launch Abstral ® (fentanyl) sublingual tablet net revenue was $1.6 million in Q3 2014 and $6.1 million to date this year, with reiterated guidance of $8-$10 million for the full year 2014 Zuplenz ® (ondansetron) Oral Soluble Film U.S. rights licensed; launch expected in Q1 2015 Conference call scheduled for 5:00 pm E.T. today with details below
PORTLAND, Ore., Nov.
National Health Investors, Inc. (NYSE:NHI) announced today its
Normalized Funds From Operations (“FFO”), its Normalized Adjusted Funds
From Operations (“AFFO”), its Normalized Funds Available for
Distribution ("FAD") and net income attributable to common stockholders
for the three and nine months ended September 30, 2014.
Urstadt Biddle Properties Inc. (the “Company”) (NYSE:UBA), a
self-administered equity real estate investment trust, today announced
the closing of its previously announced underwritten public offering of
2,500,000 shares of its Class A common stock, resulting in $52.05
million of proceeds to the Company before offering expenses.
Popeyes Louisiana Kitchen, Inc. (NASDAQ: PLKI), the franchisor and
operator of Popeyes® restaurants, today announced that its Quarterly
Report on Form 10-Q for its third quarter 2014, which ended October 5,
2014, will be filed on Wednesday, November 12, 2014, after market close.
Gross merchandise volume reached a third quarter record of $130.5 million Total revenue reached a third quarter record of $31.3 million Ecommerce services revenue increased 37% year over year to a third quarter record of $15.8 million Successfully reduced logistics costs by 8% A third quarter record Adjusted EBITDA of $0.3 million 24 new customer wins year to date, including John Varvatos, Orvis, Deb Shops and Orchard Brands Signed footwear retailer Dune London as first UK customer
NEW YORK, Nov.
Imperial Holdings, Inc. (NYSE: IFT) announced today that its Board of
Directors has adopted a by-law that requires a shareholder, before
filing a lawsuit against the company, its board of directors or its
officers, to obtain consents of shareholders beneficially owning at
least three (3) percent of Imperial’s common shares.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.